AFP and hepatocellular carcinoma: An overall decline in AFP suggests a favorable response to treatment and a shift away from a cold phenotype, since AFP plays a role in HCC escaping immune surveillance by inhibiting lymphocyte and macrophage function and maturation and activation of DCs [156].